The expression of galectin-1 in vulvar neoplasia

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1547-1552

  Kohrenhagen, Nico ^a   Voelker, Hans Ullrich ^a   Kapp, Michaela ^a   Dietl, Johannes ^a   Kämmerer, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Galectin 1; Immunohistochemistry; Squamous cell carcinoma; Vulvar intraepithelial neoplasia

Indexed keywords

GALECTIN 1;

CANCER GRADING; CANCER INVASION; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STROMA CELL; VULVA CANCER;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; VULVA; VULVAR NEOPLASMS;

EID: 77954573759     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Jones RW, Baranyai J and Stables S: Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynaecol 90: 448, 1997.
3. Messing MJ and Gallup DG: Carcinoma of the vulva in young women. Obstet Gynecol 86: 51-54, 1995.
4. Ansink A: Vulvar squamous cell carcinoma. Semin Dermatol 15: 51-59, 1996.
5. Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y and Kirino T: Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res 59: 722-730, 2000.
6. Honjo Y, Nangia-Makker P, Inohara H and Raz A: Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 7: 661-668, 2001. (Pubitemid 32707992)
7. Yoshii T, Inohara H, Takenaka Y, Honjo Y, Akahani S, Nomura T, Raz A and Kubo T: Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol 18: 787-792, 2001.
8. Hughes RC: Galectins as modulators of cell adhesion. Biochimie 83: 667-676, 2001.
9. Ochieng J, Furtak V and Lukyanov P: Extracellular functions of galectin-3. Glycoconj J 19: 527-535, 2004.
10. Kuwabara I, Sano H and Liu FT: Functions of galectins in cell adhesion and chemotaxis. Methods Enzymol 363: 532-552, 2003. (Pubitemid 37267697)
11. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K et al: Galectins: a family of animal beta-galactoside-binding lectins. Cell 76: 597-598, 1994.
12. Barondes SH, Cooper DN, Gitt MA and Leffler H: Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269: 20807-20810, 1994. (Pubitemid 24978770)
13. Liu FT, Patterson RJ and Wang JL: Intracellular functions of galectins. Biochim Biophys Acta 1572: 263-273, 2002.
14. Perillo NL, Pace KE, Seilhamer JJ and Baum LG: Apoptosis of T-cells mediated by galectin-1. Nature 378: 736-739, 1995.
15. Blaser C, Kaufmann M, Müller C, Zimmermann C, Wells V, Mallucci L and Pircher H: Beta-galactoside-binding protein secreted by activated T-cells inhibits antigen-induced proliferation of T-cells. Eur J Immunol 28: 2311-2319, 1998. (Pubitemid 28362706)
16. Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Wolfenstein-Todel C, Riera CM and Sotomayor CE: Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T-cells: biochemical and functional characterization. J Immunol 160: 4831-4840, 1998. (Pubitemid 28215317)
17. Chung CD, Patel VP, Moran M, Lewis LA and Miceli MC: Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol 165: 3722-3729, 2000. (Pubitemid 32057278)
18. Gabius HJ, Brehler R, Schauer A and Cramer F: Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 52: 107-115, 1986. (Pubitemid 17233932)
19. Irimura T, Matsushita Y, Sutton RC, Carralero D, Ohannesian DW, Cleary KR, Ota DM, Nicolson GL and Lotan R: Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 51: 387-393, 1991.
20. Lotan R, Matsushita Y, Ohannesian D, Carralero D, Ota DM, Cleary KR, Nicolson GL and Irimura T: Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression. Carbohydr Res 213: 47-57, 1991.
21. Gillenwater A, Xu XC, el-Naggar AK, Clayman GL and Lotan R: Expression of galectins in head and neck squamous cell carcinoma. Head Neck 18: 422-432, 1996.
22. Cindolo L, Benvenuto G, Salvatore P, Pero R, Salvatore G, Mirone V, Prezioso D, Altieri V, Bruni CB and Chiariotti L: galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas. Int J Cancer 84: 39-43, 1999. (Pubitemid 29059106)
23. Chiariotti L, Berlingieri MT, De Rosa P, Battaglia C, Berger N, Bruni CB and Fusco A: Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene 7: 2507-2511, 1992.
24. Xu XC, el-Naggar AK and Lotah R: Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147: 815-822, 1995.
25. van den Brule FA, Buicu C, Berchuck A, Bast RC, Deprez M, Liu FT, Cooper DN, Pieters C, Sobel ME and Castronovo V: Expression of the 67-kDa laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Hum Pathol 27: 1185-1191, 1996. (Pubitemid 26374939)
26. Kohrenhagen N, Volker HU, Kapp M, Dietl J and Kammerer U: Increased expression of galectin-1 during the progression of cervical neoplasia. Int J Gynecol Cancer 16: 2018-2022, 2006. (Pubitemid 44924365)
27. Rorive S, Belot N, Decaestecker C, Lefranc F, Gordower L, Micik S, Maurage CA, Kaltner H, Ruchoux MM, Danguy A, Gabius HJ, Salmon I, Kiss R and Camby I: Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 33: 241-255, 2001. (Pubitemid 32219133)
28. van den Brûle FA, Waltregny D and Castronovo V: Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 193: 80-87, 2001.
29. Lee JW, Song SY, Choi JJ, Choi CH, Kim TJ, Kim J, Lee JH, Kim BG and Bae DS: Decreased galectin-3 expression during the progression of cervical neoplasia. J Cancer Res Clin Oncol 132: 241-247, 2006. (Pubitemid 43144260)
30. Ellerhorst J, Nguyen T, Cooper DN, Lotan D and Lotan R: Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. Int J Oncol 14: 217-224, 1999.
31. Brustmann H: Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions. Int J Gynecol Pathol 25: 30-37, 2006.
32. Danguy A, Camby I and Kiss R: Galectins and cancer. Biochim Biophys Acta 1572: 285-293, 2002.
33. Noël A and Foidart JM: The role of stroma in breast carcinoma growth in vivo. J Mammary Gland Biol Neoplasia 3: 215-225, 1998.
34. Johnsen M, Lund LR, Rømer J, Almholt K and Danø K: Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671, 1998. (Pubitemid 28477027)
35. van den Brûle FA, Waltregny D, Liu FT and Castronovo V: Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 89: 361-367, 2000. (Pubitemid 30620290)